Skip to main content
. 2023 May 12;29(8):820–824. doi: 10.1016/j.jiac.2023.05.003

Table 1.

Base and amino acid substitutions/deletions in isolated SARS-CoV-2 after COVID-19 symptoms began.

Base substitution and deletion*
G910A
T911A, C912A
C2197T
T3161C
6513-6515 Del
G8868A
G23048A
C24054T
G24521T
T28417C
Amino acid substitution S36 N in NSP2 S148P in NSP3 S1265del and L1266I in NSP3 G105D in NSP4 G496S in S A831V in S V987F in S I45T in ORF9b
Day 47
Day 60
Day 66
Day 71
Day 78
Day 92
Day 100

Footnote: Remdesivir administration: first, between day 1–5 (five days); second, from day 72–81 (10 days); third, from day 102–111 (10 days). *These base substitutions and a deletion are relative to the reference strain Wuhan-Hu-1/2019 (GenBank accession number MN908947).

Abbreviations: Del, deletion; NSP, non-structural protein; S, spike protein; ORF, open-reading frame; -, no substitution detected; ○, synonymous mutation; ●, non-synonymous mutation.